Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04122703 · ClinicalTrials.gov registry record · NA

Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction

A NA study of Female Sexual Dysfunction, sponsored by Stony Brook University.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT04122703: Completed NA study of Female Sexual Dysfunction, sponsored by Stony Brook University.

NCT04122703 is a NA study of Female Sexual Dysfunction that has completed, run by Stony Brook University. The registered enrollment target is 66 participants, below the 73-participant average among 4 other Female Sexual Dysfunction trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04122703, a NA study of Female Sexual Dysfunction, has completed, sponsored by Stony Brook University.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand the efficacy of PTNS versus a placebo in the treatment of female sexual dysfunction syndrome.

Primary Outcome

Female Sexual Function Index (FSFI) is a 19-item questionnaire used to assess female sexual function. Minimum score is 1.2 and maximum score is 36. A score of 26.55 or lower is classified as sexual dysfunction

Conditions Studied

Interventions

  • DEVICE percutaneous tibial nerve stimulation (PTNS)
  • DEVICE Sham procedure

Study Locations (1)

New York

  • Stony Brook Medicine Women's Pelvic Health And Continence Center - Stony Brook

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2019-09-15
Est. Completion 2023-06-30
Phase NA
Stony Brook University

127 total trials

What the finished NCT04122703 record still lists

NCT04122703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 73-participant average among 4 other Female Sexual Dysfunction trials with a reported enrollment target (10% lower).

The record links to 1 condition, with Female Sexual Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which percutaneous tibial nerve stimulation (PTNS) is the first listed.

NCT04122703 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04122703 about?

NCT04122703 is a clinical study titled "Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction". The purpose of this study is to understand the efficacy of PTNS versus a placebo in the treatment of female sexual dysfunction syndrome.

What is the current status of trial NCT04122703?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2019-09-15. Estimated completion is 2023-06-30.

What conditions does trial NCT04122703 study?

This clinical trial studies the following conditions: Female Sexual Dysfunction.

What interventions are being tested in trial NCT04122703?

The interventions under investigation include: percutaneous tibial nerve stimulation (PTNS) (DEVICE), Sham procedure (DEVICE).

Who is sponsoring clinical trial NCT04122703?

This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04122703 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Female Sexual Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04122703, the US trial registry maintained by the National Library of Medicine. NCT04122703 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.